Guest View
User: Pass: | become a member
Author Archive for Insider Scoop

Benzinga's M&A Chatter for Wednesday May 20, 2015

Courtesy of Benzinga.

Benzinga's M&A Chatter for Wednesday May 20, 2015

The following are the M&A deals, rumors and chatter circulating on Wall Street for Wednesday May 20, 2015:

Altice CEO Says Most US Cable Companies In-Play

The CEO Comments:
Shares of Time Warner Cable (NYSE: TWC) and Cablevision (NYSE: CVC) surged higher Wednesday, following comments from the CEO of France’s Altice, that all U.S. cable companies other than Comcast (NASDAQ: CMCSA) were in play. Dexter Goei was speaking following the announcement of Altice’s acquisition of SuddenLink.

Goeli did declined comment on a Reuters report Tuesday, that Time Warner Cable had been in takeover talks with Altice. Cablevision declined comment and a Time Warner Cable spokesperson was unavailable for comment.

Time Warner Cable shares rose more than 5% Wednesday, to close at $166.55. Cablevision shares rose 18% to close at $24.69.

Monsanto Confident Deal With Syngenta Can Get Done

The Potential Deal:
Monsanto (NYSE: MON) stated Wednesday, that it is confident in its ability to address regulatory concerns, as it contemplates a deal to acquire Syngenta (NYSE: SYT). Monsanto said this could be accomplished by selling Syngenta’s seeds and traits assets.

A Syngetna spokesperson said the regulatory obstacles are not as simple as portrayed by Monsanto. Syngenta rejected a CHF449 per share bid from Monsanto on May 8.

Syngenta shares gained more than 4% Wednesday, closing at $4.68

Partnerre Board Seeks To Engage Exor For Potential Transaction

The Letter:
Shares of PartnerRE (NYSE: PRE) spiked higher premarket Wednesday, as the company sent a letter to the Exor (OTC: EXOSF) Board saying it is prepared to engage with Exor to determine whether Exor’s offer can be improved so that it is compelling, on price and terms.

Axis Capital Holdings said on May 17 it wouldn’t raise its offer for PartnerRe, believing its proposal of $132 per share in stock, plus a special dividend of $11.50 per share, is superior to the $137.50 all-cash offer from Italy’s Exor

Spa (OTC: EXOSF), according to sources reported by Reuters.

PartnerRE closed Wednesday at $134.31, a gain of $0.14

CVS Said to be in Advanced Talks to Acquire Omnicare

The Rumor:
Following some…
continue reading

10 Must Watch Stocks for Today

Courtesy of Benzinga.

10 Must Watch Stocks for Today

Related DLTR
Earnings Scheduled For May 21, 2015
What To Expect From Dollar Tree's Earnings
Tracking John Paulson's Paulson & Company Portfolio – Q1 2015 Update (Seeking Alpha)

Related HPQ
Earnings Scheduled For May 21, 2015
Almost-Flat Earnings Expected At Hewlett-Packard
Notable earnings after Thursday's close (Seeking Alpha)

Some of the stocks that may grab investor focus today are:

Wall Street expects Dollar Tree, Inc. (NASDAQ: DLTR) to report its Q1 earnings at $0.75 per share on revenue of $2.20 billion. Dollar Tree shares fell 0.43 percent to $75.93 in after-hours trading.

Williams-Sonoma, Inc. (NYSE: WSM) reported upbeat earnings for the first quarter. However, the company issued weak forecast for the second quarter. Williams-Sonoma shares surged 3.99 percent to $81.00 in the after-hours trading session.

Analysts expect Hewlett-Packard Company (NYSE: HPQ) to post its Q2 earnings at $0.86 per share on revenue of $25.63 billion. Hewlett-Packard shares slipped 0.99 percent to close at $33.07 yesterday., inc. (NYSE: CRM) reported better-than-expected earnings for the first quarter and lifted its sales outlook for the full year. shares jumped 6.88 percent to $74.99 in pre-market trading.

Analysts are expecting Best Buy Co Inc (NYSE: BBY) to have earned $0.29 per share on revenue of $8.46 billion in the first quarter. Best Buy shares declined 0.30 percent to $33.68 in after-hours trading.

NetApp Inc. (NASDAQ: NTAP) reported weaker-than-expected earnings for its fiscal fourth quarter on Wednesday. NetApp shares dipped 8.15 percent to $32.45 in pre-market trading.

Wall Street expects Gap Inc (NYSE: GPS) to post its Q1 earnings at $0.56 per share on revenue of $3.75 billion. Gap shares rose 0.52 percent to $38.87 in after-hours trading.

L Brands Inc (NYSE: LB) reported better-than-expected earnings for the first quarter, but the company issued a weak forecast for the current quarter. However, the company lifted its earnings forecast for the full year. L Brands shares slipped 1.38 percent to $87.48 in the after-hours trading session.

Cato Corp (NYSE: CATO) is projected to report its Q1 earnings at $1.09 per share on revenue of $287.40 million. Cato shares dropped 0.18 percent to close at $38.66 yesterday.

Analysts expect Ross Stores, Inc. (NASDAQ: ROST) to post its Q1 earnings at $1.28 per share on revenue of $2.89 billion. Ross Stores shares dropped 0.03 percent to $100.90 in after-hours trading.

Posted-In: Stocks To WatchEarnings News Guidance Pre-Market Outlook Markets Trading Ideas

Risks For Alibaba, Yahoo And Internet Stocks? Bernstein Just Laid Them Out

Courtesy of Benzinga.

Risks For Alibaba, Yahoo And Internet Stocks? Bernstein Just Laid Them Out
Related BABA
Benzinga's Top Initiations
Bernstein Initiates Alibaba With $120 PT On Mobile Monetization Growth
Goldman updates list of most-held hedge fund names (Seeking Alpha)
Related YHOO
Stocks On The Move Following JP Morgan Global Technology, Media And Telecom Conference
Competition & Cord-Cutting Push Old/New Media Hook-Ups – More To Come?
Goldman updates list of most-held hedge fund names (Seeking Alpha)

Alibaba Group Holding Ltd (NYSE: BABA) shares are rising nearly 1 percent on Thursday morning on the back of an initiation at Bernstein. The Wall Street firm holds an Outperform rating on the Internet giant with a $120 price target.

Aside from the headline news, there's also an interesting section on downside risk buried in the report. Below is what Bernstein laid out on the sector, Alibaba and Yahoo.

U.S. Internet Sector Risks

  1. "Global economic conditions: Consumer and advertising spend are the main drivers of revenue for all companies in our coverage, and deterioration of economic conditions could have a material negative impact on revenues and earnings of all companies in our coverage."
  2. "Cyber-security: All companies in our coverage depend on the global Internet. Their data (including user-data), infrastructure, and services could be compromised either by malicious attackers or by an "act of God" that compromises major portions of their Internet infrastructure. This could have a major negative impact on revenues and earnings of all companies in our coverage."
  3. "Network neutrality: Companies in our coverage pay telecommunications service providers for terminating their traffic in accordance to local regulation and business practices, either directly or through third-parties (e.g., CDNs). They do not pay to ensure that their traffic is delivered to the end user with a higher or lower priority than other traffic from the Internet. If fixed or mobile telecommunications service providers were to charge Internet companies for the delivery of bits beyond the usual traffic termination charges, the revenues, earnings and stock prices of

continue reading

Nomura Upgrades Vodafone Group To Neutral

Courtesy of Benzinga.

Related VOD
Morning Market Losers
Benzinga's Top #PreMarket Losers
Cable Deal Sparks M&A Talk (Investor’s Business Daily)

Nomura upgraded Vodafone Group Plc (ADR) (NASDAQ: VOD) from Reduce to Neutral.

Vodafone Group shares have gained 7.87 percent over the past 52 weeks, while the S&P 500 index has surged 12.33 percent in the same period.

Vodafone Group shares climbed 1.78 percent to $37.80 in pre-market trading.

Latest Ratings for VOD

Date Firm Action From To
May 2015 Nomura Upgrades Reduce Neutral
Feb 2015 Bank of America Downgrades Neutral Underperform
Oct 2014 Deutsche Bank Initiates Coverage on Buy

View More Analyst Ratings for VOD
View the Latest Analyst Ratings

Posted-In: NomuraUpgrades Analyst Ratings

4 SMID-Cap Biotechs Barclays Just Confessed It Loves

Courtesy of Benzinga.

Related ALKS
Barclays Initiates Alkermes With Overweight
Alkermes 'Taking A Pause,' Citi Says
Related ESPR
7 Biotech Stocks Moving Off The UBS Healthcare Conference
3 Diverse Stocks This Expert Is Watching (In 3 Charts)

In a new research note, Barclays analysts said that the run in biotech stocks is not over. In fact, the firm initiated coverage on four names, three of which it started with Overweight ratings.

On that Overweight side, Barclays likes Alkermes Plc (NASDAQ: ALKS), Esperion Therapeutics Inc (NASDAQ: ESPR), and Intercept Pharmaceuticals Inc (NASDAQ: ICPT). The firm also initiated coverage on Trevena Inc (NASDAQ: TRVN), with an Equal-Weight rating.

These companies develop pharmaceuticals that deal with a range of issues, from depression and schizophrenia (Alkermes) to high cholesterol (Esperion), liver fibrosis (Intercept) and pain management (Trevena). Barclays said that it expects the SMID-cap biotech industry to continue to "remain integral to the innovation momentum in healthcare and provide growth opportunities for some time."

For the SMID-cap sector, the analysts also noted that there is obviously an M&A component, as well as opportunities for SMID to partner with large biopharma. That leaves opportunities for many of these names to continue to run higher. Here are the specifics:

The analysts noted that there are key risks for SMID-biotech companies, notably rising reimbursement hurdles in the U.S., as well as the potential that the M&A boom will slow.

  • Alkermes: Barclays forecasted that this stock will reach $74, up from a $62.10 closing price on Wednesday. The analysts said Alkermes has important catalysts in the next 12 months that will offer insight into its late-stage psychiatry pipeline and the commercial potential of key programs. In particular, the analysts pointed to Q1 2016 Phase 3 data for its depression drug.
  • Esperion Therapeutics: While noting that shares of Esperion have had a "historic run over the past six months" – up more than 293 percent – Barclays said the price could rise another 30 percent to the firm's $150 price target.

continue reading

SunTrust Robinson Humphrey Upgrades LaSalle Hotel Properties To Neutral

Courtesy of Benzinga.

Related LHO
Top 4 Mid-Cap Stocks In The REIT-Hotel/Motel Industry With The Highest Operating Margin
Citigroup: Lodging/Hotel REIT Earnings Preview
SunTrust upgrades lodging REIT names (Seeking Alpha)

SunTrust Robinson Humphrey upgraded LaSalle Hotel Properties (NYSE: LHO) from Reduce to Neutral.

The price target for LaSalle Hotel Properties is set to $39.

LaSalle Hotel Properties shares have gained 14.58 percent over the past 52 weeks, while the S&P 500 index has surged 12.33 percent in the same period.

LaSalle Hotel Properties’ shares closed at $37.09 yesterday.

Latest Ratings for LHO

Date Firm Action From To
May 2015 SunTrust Robinson Humphrey Upgrades Reduce Neutral
Mar 2015 SunTrust Robinson Humphrey Downgrades Neutral Reduce
Mar 2015 Deutsche Bank Maintains Hold

View More Analyst Ratings for LHO
View the Latest Analyst Ratings

Posted-In: SunTrust Robinson HumphreyUpgrades Analyst Ratings

Salesforce Fair Value Now $76/Share

Courtesy of Benzinga.

Related CRM
10 Must Watch Stocks for Today
Williams-Sonoma,, Deckers Outdoor Lead Wednesday's After-Hours Movers
Wall Street Breakfast: PMI Data Weighs On Global Markets (Seeking Alpha)

In a report published Thursday, Brean Capital analysts maintained a Hold rating on, inc. (NYSE: CRM), while raising the fair value from $70 to $76, after the company reported robust 1Q results and raised its FY16 outlook. reported robust 1Q results, with better than-expected total reported billings and non-GAAP operating margins. The company’s total revenue of $1.51 billion was largely in-line.

The company noted that the number of 7-figure-plus deals signed during the quarter were the highest ever for any of the first quarters and that 30 percent of the top deals were net new customers.’s Services Cloud grew 38.3- percent year on year and its new Wave Analytics segment saw good early activity. “We were also pleased to hear management note that Wave Analytics is displacing legacy BI vendors, being used as a tier-two deployment, and also in entirely new instances where the company sees greenfield,” the analysts mentioned.

The company has guided to in-line 2Q revenues and EPS, implying weaker-than consensus billings in the quarter. “We had suspected the company would guide conservatively, given the potential disruption from M&A chatter, and we continue to highlight the Reported Billings are not a useful metric on a quarterly basis,” the analysts added. raised its FY16 revenue and EPS guidance from $6.475-$6.52 billion to $6.52-$6.55 billion and from $0.67-$0.69 to $0.69-$0.71, respectively.

Latest Ratings for CRM

Date Firm Action From To
May 2015 Stifel Nicolaus Maintains Buy
Apr 2015 CLSA Downgrades Buy Outperform
Mar 2015 Brean Capital Initiates Coverage on Hold

View More Analyst Ratings for CRM
View the Latest Analyst Ratings

Posted-In: Brean CapitalAnalyst Color Price Target Reiteration Analyst Ratings

Apple iPhone, Watch Estimates Boosted At Morgan Stanley On 'Strong Demand'

Courtesy of Benzinga.

Related AAPL
Why Spotify's New Features Pose A Threat To Apple, But Not To Netflix
Apple: The Technical And Fundamental View For The Short Term
Semiconductor Stock Outlook – May 2015 – Zacks Analyst Interviews (Zacks)

In a report published Thursday, Morgan Stanley analysts maintained an Overweight rating on Apple Inc (NASDAQ: AAPL), with a price target of $166. The analysts raised the iPhone and Apple Watch estimates after their AlphaWise Smartphone Tracker and US Wearables survey indicated robust demand.

“Our AlphaWise Smartphone Tracker, which compiles sell-through data using web search analysis, indicates 53M unit end demand for the current quarter. Importantly, demand continues to top expectations despite Apple approaching the end of the current product cycle,” the analysts wrote.

The data indicated that strong y/y growth is being driven by the emerging markets, especially China.

Morgan Stanley has maintained or raised its iPhone builds every month in the iPhone 6 and 6 Plus cycle, with demand continuing to be stronger than expected. The estimate for iPhone units for the June quarter has been raised from 46M to 50M. The estimates for FY15 and FY16 have been raised by 5 percent to 240M and by 7 percent to 249M.

“Apple Watch demand increased consistently over the past six months across three comparable AlphaWise surveys of US consumers. Importantly, Apple enjoyed the biggest increase in Watch purchase intentions post making the product available in mid-April,” the analysts said. The estimate for Watch units in the first 12 months has been raised by 20 percent from 30M to 36M.

The EPS estimates for 2015, 2016 and 2017 have been raised from $8.94 to $9.32, from $9.83 to $10.66 and from $10.70 to $11.72, respectively.

Latest Ratings for AAPL

Date Firm Action From To
Apr 2015 Canaccord Genuity Maintains Buy
Apr 2015 Susquehanna Maintains Positive
Apr 2015 Jefferies Maintains Hold

View More Analyst Ratings for AAPL
View the Latest Analyst Ratings

Posted-In: Morgan StanleyAnalyst Color Reiteration Analyst Ratings

Canaccord: SAGE Therapeutics Now Worth $85/Share On 'Higher Probability Of Success' For Drug

Courtesy of Benzinga.

Goldman Sachs Initiates SAGE Therapeutics On 'Great' Orphan Drug Potential
SAGE Therapeutics Posts Q1 Loss

In a report published Thursday, Canaccord Genuity analysts maintained a Buy rating on SAGE Therapeutics Inc (NASDAQ: SAGE), while raising the price target from $58 to $85, to reflect a higher probability of success for SAGE-547.

The analysts believe SAGE-547 is poised to hit the primary endpoint in the upcoming Phase 3 STATUS trial, “which is successful weaning off of anesthesia and all AE drugs without recurrence of SE within 24 hours, due to continued positive data in its Phase 1/2 trials.”

The Phase 3 trial is scheduled to enroll 126 patients to either SAGE-547 versus standard of care third-line anti-seizure agents. The trial would continue for six days and the top-line data can be expected in mid-2016. “Importantly, the study will include a crossover and retreatment with a higher dose if no initial response, which we believe may provide a more definitive demonstration of efficacy,” the analysts said.

Phase 2 data for SAGE-547 in Essential Tremor (ET) and severe PostPartum Depression (PPD) by mid-215 could be a near-term catalyst, provided they exhibit early efficacy.

In the report Canaccord Genuity noted, “Although data are ~12 months away, we believe that finalization of the Phase 3 design and enrollment will increase investor diligence near term. We believe the Phase 3 trial design of a placebo-controlled study vs. an open-label historical control will provide unambiguous evidence of efficacy for SAGE-547 vs. placebo, especially due to the high level of confounding variables that may occur in this complicated patient population if an open-label study was run.”

Latest Ratings for SAGE

Date Firm Action From To
May 2015 Goldman Sachs Initiates Coverage on Buy
Apr 2015 JP Morgan Maintains Overweight
Jan 2015 SunTrust Robinson Humphrey Initiates Coverage on Buy

View More Analyst Ratings for SAGE
View the Latest Analyst Ratings

Posted-In: Canaccord GenuityAnalyst Color Price Target Reiteration Analyst Ratings

Lumber Liquidators Shares Get Chopped

Courtesy of Benzinga.

Related LL
Stocks Hitting 52-Week Lows
Morning Market Losers
Lumber Liquidators CEO Quits Amid Toxic Floor Probe (Investor’s Business Daily)

Shares of Lumber Liquidators Holdings Inc (NYSE: LL) are sliding down 14 percent from Wednesday’s close of $25.27 on news that its CEO unexpectedly resigned.

Shares traded recently at $21.75, down 13.9 percent.

See Also: Lumber Liquidators Stock Collapsing After 'Unexpected' Resignation

The news shocked investors, causing the stock to sink as low as $18.76 on panic trading in the pre-market session. This represented about a 26 percent decrease. Shares gradually rebounded back up to $21.81 level after the market open.

The company’s stock price has been struggling tremendously, dwindling roughly 70 percent in the past three months on the news that the company suspended all laminate flooring sales made in China amid a "60 Minutes" report.

Year-to-date, shares are now down more than 67 percent, or about $44 per share.

Posted-In: Technicals Movers Trading Ideas


Zero Hedge

Smart Money Entering Precious Metals as Russia Buys Another 300,000 Ounces

Courtesy of ZeroHedge. View original post here.

Submitted by GoldCore.

Today’s AM LBMA Gold Price was USD 1,211.00, EUR 1,083.45 and GBP 772.96 per ounce.
Yesterday’s AM LBMA Gold Price was USD 1,209.60, EUR 1,084.36 and GBP 772.60 per ounce.

Gold fell $3.78 to close at $1,205.82 an ounce on yesterday, and silver remained unchanged at $17.12 an ounce.

Gold in U.S. Dollars - 1 Week

Overnight, ...

more from Tyler

Kimble Charting Solutions

King Dollar & Crude Oil reversing ST trends, says Joe Friday

Courtesy of Chris Kimble.


King Dollar and Crude Oil have been have had little correlation over the past year, as each has traded in pretty much opposite directions.

Over the past 9 months King Dollar has had a historical rally and the opposite is true for Crude Oil.

Of late Crude hit its 23% Fibonacci resistance line, based upon last summers weekly closing highs and weekly closing low on 3/13/15.

Joe Friday just the facts….Crude oil is making an attempt to break short-term steep rising support this week and King Dollar is attempting to break short-term steep falling resistance.

Crude oil just experienced its 7th largest 2-month rally in its...

more from Kimble C.S.

Chart School

April Consumer Price Index: Core Inflation Remains Steady, Headline Deflation Worsens

Courtesy of Doug Short.

The Bureau of Labor Statistics released the April CPI data this morning. The year-over-year unadjusted Headline CPI came in at -0.20% (rounded to -0.2%), down from -0.07% (rounded to -0.1%) the previous month. Year-over-year Core CPI (ex Food and Energy) came in at 1.81% (rounded to 1.8%), unchanged to one decimal pace from the previous month's 1.75% (rounded to 1.8%).

Here is the introduction from the BLS summary, which leads with the seasonally adjusted monthly data:

The Consumer Price Index for All Urban Consumers (CPI-U) increased 0.1 percent in April on a seasonally adjusted basis, the U.S. Bureau of Labor Statistics reported today. Over the last 12 months, the all items index declined 0.2 percent before seasonal adjustment. The index for all items less food and energy rose 0.3 percent in April and led to the slight increase in the ...

more from Chart School

Phil's Favorites

Another US Foreign Policy Success: Isis Controls Half of Syria after Palmyra Seizure

Courtesy of Mish.

Congratulations are in order for team Bush and team Obama for another stunning US foreign policy success: Isis Controls Half of Syria after Palmyra Seizure. Fighters from the Islamic State of Iraq and the Levant (Isis) have seized the Syrian city of Palmyra, home to a Unesco world heritage site, putting nearly half of Syrian territory in the jihadi group’s hands and sparking fears that treasured antiquities may be destroyed.

Isis announced it had “complete control” of the city on Thursday, and state television said President Bashar al-Assad’s forces had withdrawn from the city, which is known to most Syrians by its Arabic name Tadmur.

Ancient Palmyra is known to the world for its iconic avenue ...

more from Ilene

All About Trends

Mid-Day Update

Reminder: David is available to chat with Members, comments are found below each post.

Click here for the full report.

To learn more, sign up for David's free newsletter and receive the free report from All About Trends - "How To Outperform 90% Of Wall Street With Just $500 A Week." Tell David PSW sent you. - Ilene...

more from David

Insider Scoop

Salesforce Fair Value Now $76/Share

Courtesy of Benzinga.

Related CRM 10 Must Watch Stocks for Today Williams-Sonoma,, Deckers Outdoor Lead Wednesday's After-Hours Movers Wall Street Breakfast: PMI Data Weighs On Global Markets (Seeking Alpha)

In a report published Thursday, Brean Capital analysts maintained a Hold rating on, inc. (NYSE: ... more from Insider


Big Pharma's Business Model is Changing

Reminder: Pharmboy is available to chat with Members, comments are found below each post.

Understanding the new normal of a business model is key to the success of any company.  The managment of companies need to adapt to the changing demand, but first they must recognize what changes are taking place.  Big Pharma's business model is changing rapidly, and much like the airline industry, there will be but a handful of pharma companies left at the end of this path.

Most Big Pharma companies have traditionally done everything from research and development (R&D) through to commercialisation themselves. Research was proprietary, and diseases were cherry picked on the back of academic research that was done using NIH grants.  This was in the heyday of research, where multiple companies had drugs for the same target (Mevocor, Zocor, Crestor, Lipitor), and could reap the rewards on multiple scales.  However, in the c...

more from Pharmboy


Sector Detector: Bullish technical picture appears to trump cautious fundamentals

Reminder: Sabrient is available to chat with Members, comments are found below each post.

Courtesy of Sabrient Systems and Gradient Analytics

By Scott Martindale

Stocks closed last week on a strong note, with the S&P 500 notching a new high, despite lackluster economic data and growth. I have been suggesting in previous articles that stocks appeared to be coiling for a significant move but that the ingredients were not yet in place for either a major breakout or a corrective selloff. However, bulls appear to be losing patience awaiting their next definitive catalyst, and the higher-likelihood upside move may now be underway. Yet despite the bullish technical picture, this week’s fundamentals-based Outlook rankings look even more defensive.

In this weekly update, I give ...

more from Sabrient


Swing trading portfolio - week of May 18th, 2015

Reminder: OpTrader is available to chat with Members, comments are found below each post.


This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...

more from OpTrader

Digital Currencies

Nasdaq's bitcoin plan will provide a real test of bitcoin hype


Nasdaq's bitcoin plan will provide a real test of bitcoin hype



Bitcoin, the virtual digital currency, has been called the future of banking, a dangerous fad, and almost everything in between, but we're finally about to get some solid data to help settle the debate.

On Monday, the Nasdaq (NDAQ) stock exchange said it would ...

more from Bitcoin

Market Shadows

Kimble Charts: US Dollar

Which way from here?

Chris Kimble likes the idea of shorting the US dollar if it bounces higher. Phil's likes the dollar better long here. These views are not inconsistent, actually, the dollar could bounce and drop again. We'll be watching. 


Phil writes:  If the Fed begins to tighten OR if Greece defaults OR if China begins to fall apart OR if Japan begins to unwind, then the Dollar could move 10% higher.  Without any of those things happening – you still have the Fed pursuing a relatively stronger currency policy than the rest of the G8.  So, if anything, I think the pressure should be up, not down.  


UNLESS that 95 line does ultimately fail (as opposed to this being bullish consolidation at the prior breakout point), then I'd prefer to sell the UUP Jan $25 puts for $0.85 and buy the Sept $24 call...

more from Paul

Mapping The Market

An update on oil proxies

Courtesy of Jean-Luc Saillard

Back in December, I wrote a post on my blog where I compared the performances of various ETFs related to the oil industry. I was looking for the best possible proxy to match the moves of oil prices if you didn't want to play with futures. At the time, I concluded that for medium term trades, USO and the leveraged ETFs UCO and SCO were the most promising. Longer term, broader ETFs like OIH and XLE might make better investment if oil prices do recover to more profitable prices since ETF linked to futures like USO, UCO and SCO do suffer from decay. It also seemed that DIG and DUG could be promising if OIH could recover as it should with the price of oil, but that they don't make a good proxy for the price of oil itself. 


more from M.T.M.


Watch the Phil Davis Special on Money Talk on BNN TV!

Kim Parlee interviews Phil on Money Talk. Be sure to watch the replays if you missed the show live on Wednesday night (it was recorded on Monday). As usual, Phil provides an excellent program packed with macro analysis, important lessons and trading ideas. ~ Ilene


The replay is now available on BNN's website. For the three part series, click on the links below. 

Part 1 is here (discussing the macro outlook for the markets) Part 2 is here. (discussing our main trading strategies) Part 3 is here. (reviewing our pick of th...

more from Promotions

Help One Of Our Own PSW Members

"Hello PSW Members –

This is a non-trading topic, but I wanted to post it during trading hours so as many eyes can see it as possible.  Feel free to contact me directly at with any questions.

Last fall there was some discussion on the PSW board regarding setting up a YouCaring donation page for a PSW member, Shadowfax. Since then, we have been looking into ways to help get him additional medical services and to pay down his medical debts.  After following those leads, we are ready to move ahead with the YouCaring site. (Link is posted below.)  Any help you can give will be greatly appreciated; not only to help aid in his medical bill debt, but to also show what a great community this group is.

Thank you for you time!

FeedTheBull - Top Stock market and Finance Sites

About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>

As Seen On:

About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>